Chapter 5: Blood pressure management in kidney transplant recipients (CKD T).
出版信息
Kidney Int Suppl (2011). 2012 Dec;2(5):370-371. doi: 10.1038/kisup.2012.55.
Abstract
摘要
相似文献
1
Chapter 5: Blood pressure management in kidney transplant recipients (CKD T).第5章：肾移植受者（慢性肾脏病5期）的血压管理
Kidney Int Suppl (2011). 2012 Dec;2(5):370-371. doi: 10.1038/kisup.2012.55.
2
Cardiac troponins in patients with chronic kidney disease and kidney transplant recipients without acute cardiac symptoms.慢性肾脏病患者及无急性心脏症状的肾移植受者的心肌肌钙蛋白
Iran J Kidney Dis. 2014 Jan;8(1):31-6.
3
Management of chronic kidney disease after renal transplantation: is it different from nontransplant patients?肾移植后慢性肾脏病的管理：与非移植患者有何不同？
Transplant Proc. 2009 Jul-Aug;41(6):2409-11. doi: 10.1016/j.transproceed.2009.06.107.
4
Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.大多数肾移植受者以及患有或未患有并发症的冠状动脉疾病患者的血压控制不佳。
Transplant Proc. 2009 Oct;41(8):3069-72. doi: 10.1016/j.transproceed.2009.07.078.
6
Clinical course of dengue fever and its impact on renal function in renal transplant recipients and patients with chronic kidney disease.登革热在肾移植受者和慢性肾脏病患者中的临床病程及其对肾功能的影响。
Nephrology (Carlton). 2019 May;24(5):564-568. doi: 10.1111/nep.13265.
7
Is Kidney Transplantation a Better State of CKD? Impact on Diagnosis and Management.肾移植是慢性肾脏病的更佳状态吗？对诊断和管理的影响。
Adv Chronic Kidney Dis. 2016 Sep;23(5):287-294. doi: 10.1053/j.ackd.2016.09.006.
8
Management and Outcomes of ST-Segment Elevation Myocardial Infarction in US Renal Transplant Recipients.美国肾移植受者中 ST 段抬高型心肌梗死的管理与结局。
JAMA Cardiol. 2017 Mar 1;2(3):250-258. doi: 10.1001/jamacardio.2016.5131.
9
Prevalence of Arterial Stiffness and Associated Factors in Thai Patients with Chronic Kidney Disease and Kidney Transplant Recipients.泰国慢性肾脏病患者及肾移植受者的动脉僵硬度患病率及相关因素
J Med Assoc Thai. 2017 Feb;100 Suppl 1:S56-69.
10
Metabolic syndrome in chronic kidney disease and renal transplant patients in North India.印度北部慢性肾脏病和肾移植患者的代谢综合征。
Int Urol Nephrol. 2012 Jun;44(3):937-43. doi: 10.1007/s11255-011-9998-6. Epub 2011 Jun 10.
本文引用的文献
1
Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.加拿大移植学会和加拿大肾脏病学会对2009年KDIGO肾移植受者护理临床实践指南的评论
Am J Kidney Dis. 2010 Aug;56(2):219-46. doi: 10.1053/j.ajkd.2010.05.004.
2
Cardioprotective medication use after renal transplantation.肾移植后心脏保护性药物的使用。
Clin Transplant. 2010 Nov-Dec;24(6):E253-6. doi: 10.1111/j.1399-0012.2010.01297.x.
3
Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.坎地沙坦可改善肾移植受者的血压控制并减少蛋白尿：来自 SECRET 的结果。
Nephrol Dial Transplant. 2010 Mar;25(3):967-76. doi: 10.1093/ndt/gfp581. Epub 2009 Nov 3.
4
KDIGO clinical practice guideline for the care of kidney transplant recipients.KDIGO 临床实践指南：肾移植受者的护理。
Am J Transplant. 2009 Nov;9 Suppl 3:S1-155. doi: 10.1111/j.1600-6143.2009.02834.x.
5
Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials.肾移植受者的抗高血压药物：随机对照试验的系统评价和荟萃分析
Transplantation. 2009 Jul 15;88(1):7-18. doi: 10.1097/TP.0b013e3181a9e960.
6
Use of cardioprotective medications in kidney transplant recipients.心脏保护药物在肾移植受者中的应用。
Am J Transplant. 2009 Aug;9(8):1811-5. doi: 10.1111/j.1600-6143.2009.02696.x. Epub 2009 Jun 10.
7
Cardiovascular disease in transplant recipients: current and future treatment strategies.移植受者的心血管疾病：当前及未来的治疗策略
Clin J Am Soc Nephrol. 2008 Mar;3 Suppl 2(Suppl 2):S29-37. doi: 10.2215/CJN.02690707.
8
The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design.加拿大血管紧张素转换酶抑制剂改善肾移植肾结局及患者生存率试验——研究设计
Nephrol Dial Transplant. 2008 Jan;23(1):354-8. doi: 10.1093/ndt/gfm574. Epub 2007 Sep 10.
9
Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence.肾移植中肾素-血管紧张素系统阻断：证据的系统评价
Am J Transplant. 2007 Oct;7(10):2350-60. doi: 10.1111/j.1600-6143.2007.01928.x.
10
No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report.接受血管紧张素转换酶抑制剂或1型血管紧张素II受体阻滞剂治疗的移植受者的患者或移植物存活率未得到改善：一项移植协作研究报告。
J Am Soc Nephrol. 2006 Nov;17(11):3257-62. doi: 10.1681/ASN.2006050543. Epub 2006 Oct 11.
Zotero 插件